Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

被引:595
作者
Cramer, JA
Perrine, K
Devinsky, O
Bryant-Comstock, L
Meador, T
Hermann, B
机构
[1] VA Connecticut Healthcare Syst, W Haven, CT USA
[2] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[4] NYU, Dept Neurol, New York, NY 10016 USA
[5] NYU, Hosp Joint Dis, Comprehens Epilepsy Program, New York, NY 10003 USA
[6] Glaxo Wellcome, Int Pharmacoecon Res, Res Triangle Pk, NC USA
[7] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA
[8] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA
关键词
health-related quality-of-life; dimensions of health; construct validity; quality-of-life in epilepsy inventory; epilepsy; translocations;
D O I
10.1111/j.1528-1157.1998.tb01278.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We report the development of a questionnaire to assess health-related quality-of-life (HRQOL) in people with epilepsy and the process of cross-cultural translations of the questionnaire. Methods: A sample of 304 adults with epilepsy from 25 seizure clinics in the United States was used to derive an abbreviated questionnaire focusing on epilepsy-related issues from a longer, 89-item instrument (QOLIE-89). A rigorous forward-backward-forward system was used for cross-cultural translation. Results: A 31-item questionnaire (QOLIE-31, version 1.0) resulted, comprising seven subscales covering general and epilepsy-specific domains. Subscale and total scores can be calculated. The subscales were grouped into two factors: Emotional/Psychological Effects (seizure worry, overall QOL, emotional well-being, energy/fatigue subscales) and Medical/Social Effects (medication effects, work-driving-social limits, cognitive function subscales). Cross-cultural translations were made from U.S.-English into Danish, Dutch, German, Canadian French, French, Italian, Spanish, Swedish, and U.K. English Versions 1.1. Conclusions: Our results support the reliability and validity of the QOLIE-31 (U.S.-English version 1.0) as a measure of HRQOLIE. Cross-cultural translations into nine other languages make it feasible to use the QOLIE-31 (version 1.1) in multinational clinical trials after validation in each population or concurrent with the clinical trial.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 23 条
  • [1] Andrew F., 1976, SOCIAL INDICATORS WE
  • [2] [Anonymous], 1992, POMS PROFILE MOOD ST
  • [3] THE INITIAL DEVELOPMENT OF A HEALTH-RELATED QUALITY-OF-LIFE MODEL AS AN OUTCOME MEASURE IN EPILEPSY
    BAKER, GA
    SMITH, DF
    DEWEY, M
    JACOBY, A
    CHADWICK, DW
    [J]. EPILEPSY RESEARCH, 1993, 16 (01) : 65 - 81
  • [4] TESTING THE VALIDITY OF THE EUROQOL AND COMPARING IT WITH THE SF-36 HEALTH SURVEY QUESTIONNAIRE
    BRAZIER, J
    JONES, N
    KIND, P
    [J]. QUALITY OF LIFE RESEARCH, 1993, 2 (03) : 169 - 180
  • [5] A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10
    Cramer, JA
    Perrine, K
    Devinsky, O
    Meador, K
    [J]. EPILEPSIA, 1996, 37 (06) : 577 - 582
  • [6] CRAMER JA, 1994, NEUROL CLIN, V12, P1
  • [7] A METHOD OF QUANTIFICATION FOR THE EVALUATION OF ANTI-EPILEPTIC DRUG-THERAPY
    CRAMER, JA
    SMITH, DB
    MATTSON, RH
    ESCUETA, AVD
    COLLINS, JF
    BROWNE, TR
    CRILL, WE
    HOMAN, RW
    MAYERSDORF, A
    MCCUTCHEN, CB
    MCNAMARA, JO
    ROSENTHAL, NP
    TREIMAN, DM
    WILDER, BJ
    WILLIAMSON, PD
    [J]. NEUROLOGY, 1983, 33 (03) : 26 - 37
  • [8] Cramer JA, 1996, QUALITY LIFE PHARMAC, P909
  • [9] Cramer Joyce, 1995, Epilepsia, V36, P93
  • [10] DEVELOPMENT OF THE QUALITY-OF-LIFE IN EPILEPSY INVENTORY
    DEVINSKY, O
    VICKREY, BG
    CRAMER, J
    PERRINE, K
    HERMANN, B
    MEADOR, K
    HAYS, RD
    [J]. EPILEPSIA, 1995, 36 (11) : 1089 - 1104